Physician profile
Paul E Piper
NPI 1336160316
$990.01
in general payments reported to CMS, 2019-2025
21 companies · $20.46 in 2025
The $20.46 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $147 · 2021: $111 · 2022: $33.31 · 2024: $43.90 · 2025: $20.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $244.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.56 | 2019-2020 | |
| Astellas Pharma US INC | $76.15 | 2019-2024 | Veozah |
| Amgen INC. | $67.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $66.19 | 2019-2021 | |
| Abbvie INC. | $53.33 | 2021-2024 | |
| Boston Scientific Corporation | $50.19 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $42.65 | 2019 | |
| Glaxosmithkline, LLC. | $39.67 | 2019 | |
| Pfizer INC. | $39.67 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $37.04 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $31.71 | 2020 | |
| Merck Sharp & Dohme LLC | $26.64 | 2019 | |
| Hologic Sales and Service, LLC | $23.11 | 2019 | |
| Abbott Laboratories | $20.46 | 2025 | Proclaim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.36 | 2019 | |
| Upsher-Smith Laboratories LLC | $15.58 | 2019 | |
| Radius Health, INC. | $15.19 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $13.87 | 2019 | |
| Horizon Therapeutics Plc | $12.82 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Piper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.